Nov 10, 2025 04:15PM
Nov 6, 2025 11:00AM
Nov 6, 2025 11:00AM
Aug 12, 2025 04:01PM
Jul 15, 2025 07:30AM
Jul 15, 2025 07:30AM
Jul 8, 2025 07:00AM ProKidney reports positive phase 2 trial results for kidney disease therapy
Jul 8, 2025 07:00AM
Jul 1, 2025 12:44PM
Jul 1, 2025 12:43PM
May 12, 2025 04:15PM
Mar 17, 2025 07:30AM
Nov 12, 2024 07:30AM
Sep 3, 2024 07:31AM ProKidney Corp (PROK) Announces Strategic Updates to its Phase 3 Program
Sep 3, 2024 07:30AM
Aug 9, 2024 07:00AM
Jun 10, 2024 06:30AM
Jun 10, 2024 05:30AM
May 21, 2024 07:00AM
May 10, 2024 07:00AM
Mar 25, 2024 06:06AM ProKidney Corp (PROK) Announces Leadership Changes
Mar 25, 2024 06:05AM
Mar 21, 2024 07:49PM
Nov 30, 2023 06:05AM
Nov 21, 2023 06:05AM
Nov 14, 2023 06:05AM
Nov 13, 2023 05:02PM
Nov 13, 2023 05:02PM ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
Oct 30, 2023 04:12PM
Sep 5, 2023 06:05AM
Aug 10, 2023 04:10PM
Jul 18, 2023 06:05AM
Jul 17, 2023 06:05AM
Jun 13, 2023 12:05PM
Jun 1, 2023 04:05PM ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference
May 11, 2023 04:01PM
May 4, 2023 06:05AM
Mar 28, 2023 04:12PM
Mar 28, 2023 04:12PM
Mar 3, 2023 06:05AM
Jan 10, 2023 04:06PM
Jan 10, 2023 04:05PM ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease
Dec 22, 2022 06:05AM
Nov 14, 2022 06:05AM
Nov 11, 2022 04:05PM
Nov 3, 2022 06:08AM
Nov 3, 2022 06:05AM
Oct 14, 2022 12:00PM
Sep 23, 2022 06:15AM ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit
Sep 8, 2022 06:05AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All